Browse Category

Stock Market 7 July 2026 - 8 July 2026

Alphabet slides premarket as Google AI costs meet cloud headwinds

Alphabet slides premarket as Google AI costs meet cloud headwinds

Alphabet Inc. Class A comes into July 8 with more of a funding angle than a typical Google headline. Shares are down a bit in early trading, but the bigger question is whether Wall Street wants to keep backing Google’s AI spending as a high-return story, or if it starts treating it more like a cycle weighed down by dilution and debt. Nasdaq is closed for July 3 for Independence Day, with trading back to normal on Wednesday.
Intel (NASDAQ:INTC) slides as investors weigh foundry losses against AI gains

Intel (NASDAQ:INTC) slides as investors weigh foundry losses against AI gains

Intel is trading like an AI play, but the story is traders pulling back on the turnaround premium. The expenses are on the books, but the outside foundry growth isn't there yet. Nasdaq’s regular session hadn’t opened in New York; pre-market starts at 4:00 a.m. and runs to 9:30 a.m. ET, and July 8 isn’t listed as a Nasdaq holiday for 2026.
Stock Market Today: Live Updates 08.07.2026

Stock Market Today: Live Updates 08.07.2026

LIVEMarkets rolling coverageStarted: July 8, 2026, 4:00 AM EDTUpdated: July 9, 2026, 3:59 AM EDT ASX 200 dips as miners, gold stocks slide; STO, WDS climb on oil rally July 9, 2026, 3:59 AM EDT. The ASX 200 slipped with mining and gold stocks under pressure, as the market stayed cautious. Santos Ltd (STO) and Woodside Petroleum (WDS) both jumped after oil prices surged. Higher crude prices usually lift energy stocks. The energy sector stayed strong, helping offset some of the weakness in the wider market on Tuesday. Evening Wrap: ASX 200 dips on sagging mining, gold stocks, but oil
8 July 2026
Vera Therapeutics (NASDAQ:VERA) stock up; Trutakna approval shifts attention to Q3 kidney data

Vera Therapeutics (NASDAQ:VERA) stock up; Trutakna approval shifts attention to Q3 kidney data

Vera Therapeutics, Inc. finished up 7.05% at $42.96 on Tuesday after U.S. regulators approved Trutakna. The bigger investor focus was on the size of the bid. With 71.78 million shares outstanding from Google Finance and a $2.83 move on the day, that comes out to roughly $203 million more in equity value added. That’s around a third of Vera’s last reported cash, and not a big reset for a $3.08 billion biotech that’s now swapped FDA risk for launch risk.
DigitalOcean (NYSE:DOCN) pops as AI cloud trade shifts on new backlog math

DigitalOcean (NYSE:DOCN) pops as AI cloud trade shifts on new backlog math

DigitalOcean Holdings, Inc. climbed 9.3% to $143.64 Wednesday afternoon after the company forecasted its Q2 remaining performance obligations topping $800 million. That puts focus on backlog and capacity instead of just stronger AI revenue. Shares touched $157.99 at their high and 3.28 million shares changed hands as of 1:50 p.m. EDT, valuing DigitalOcean near $16.1 billion.
1 81 82 83 84 85 1,710
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.